Bridged Piperazines and Piperidines as CCR1 Antagonists with Oral Activity in Models of Arthritis and Multiple Sclerosis
暂无分享,去创建一个
P. Loetscher | P. Hiestand | A. Schlapbach | L. Révész | T. Buhl | H. Sparrer | R. Waelchli | R. Heng | J. Dawson | B. Bollbuck | R. Feifel